|
5th Annual RAS-Targeted Drug Development Summit
Conference in-person 26th to 28th September 2023 Boston, Massachusetts, United States of America Website: http://go.evvnt.com/1729218-0?pid=80 Contact person: Caitlin Crouch With the approval of the second-ever KRAS G12C inhibitor, the field can once again celebrate irrevocable proof that RAS is druggable! Time: 08:30 - 18:00. Prices: USD 2599.00 - USD 6046.00. Organized by: Hanson Wade Check the event website for more details. View all events from this organizer.
|
